Bausch Health Companies (BHC) Total Liabilities (2009 - 2026)
Bausch Health Companies (BHC) posted Total Liabilities of $25.6 billion for Q2 2026, little changed sequentially from $25.6 billion in Q1 2026, and down 5.62% YoY from $27.1 billion in Q2 2025.
Bausch Health Companies (BHC) Total Liabilities (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Total Liabilities for 18 years, with the latest figure at $25.6 billion in Q2 2026.
- Quarterly Total Liabilities fell 5.62% year-over-year to $25.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $25.6 billion (down 5.62% YoY) and the FY2025 annual result came in at $26.0 billion, down 3.19% from the prior year.
- Total Liabilities was little changed at $25.6 billion in Q2 2026 per BHC's latest filing, from $25.6 billion in the prior quarter.
- Over five years, Total Liabilities peaked at $29.2 billion in Q1 2022 and troughed at $25.2 billion in Q2 2023.
- A 5-year average of $26.6 billion and a median of $26.7 billion in 2024 frame the typical range for Total Liabilities.
- The widest YoY moves for Total Liabilities: up 7.89% in 2023, down 13.45% in 2023.
- Over 5 years, Total Liabilities stood at $25.4 billion in 2022, then advanced by 7.89% to $27.4 billion in 2023, then declined by 2.14% to $26.8 billion in 2024, then dropped by 3.19% to $26.0 billion in 2025, then decreased by 1.51% to $25.6 billion in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $25.6 billion, $25.6 billion, and $26.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.12 Bn |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | 25.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.60 Bn |
| Mar 31, 2026 | 25.58 Bn |
| Dec 31, 2025 | 25.99 Bn |
| Sep 30, 2025 | 26.47 Bn |
| Jun 30, 2025 | 27.12 Bn |
| Mar 31, 2025 | 26.66 Bn |
| Dec 31, 2024 | 26.85 Bn |
| Sep 30, 2024 | 26.78 Bn |
| Jun 30, 2024 | 26.72 Bn |
| Mar 31, 2024 | 27.09 Bn |
| Dec 31, 2023 | 27.43 Bn |
| Sep 30, 2023 | 27.30 Bn |
| Jun 30, 2023 | 25.23 Bn |
| Mar 31, 2023 | 25.30 Bn |
| Dec 31, 2022 | 25.43 Bn |
| Sep 30, 2022 | 25.87 Bn |
| Jun 30, 2022 | 27.92 Bn |
| Mar 31, 2022 | 29.23 Bn |
| Dec 31, 2021 | 29.24 Bn |
| Sep 30, 2021 | 29.39 Bn |